Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGPH20 with mFOLFIRINOX in Metastatic Pancreatic Adenocarcinoma
NCT01959139Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2014
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvorhyaluronidase alfa in pancreatic adenocarcinoma (PDAC), sponsored by SWOG Cancer Research Network. Started Jan 2014; status: completed.
02
Drugs
pegvorhyaluronidase alfa
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01959139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959139.